News Acting CDC director says MMR jabs should be split The acting director of the CDC, Jim O’Neill, has been sharply criticised after saying the MMR vaccine should be separated into three individual shots.
News ACIP votes against first-dose MMRV for under 4s ACIP votes down recommendation allowing MSD's MMRV shot as an option for children under four, but there's confusion about the coverage implications.
News FDA clears GSK's Priorix, first new MMR vaccine in 50 years With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.